CytoMed Therapeutics Limited (GDTC) Price History & Returns
How CytoMed Therapeutics Limited (GDTC) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.
The share price of $0.92 sits 8% of the way up a 52-week range of $0.68 to $3.68; 75.0% below the 52-week high; a beta of 0.05 means it has historically moved less than the market.
Total return
Price change over each trailing period, not annualised.
Year by year
0 of 3 years closed higher than the year before. Closes are the last observation in each calendar year.
Monthly closing prices
The last 36 months, newest first. 13 of 36 months closed higher than the month before. Each figure is the last close in that month.
CytoMed Therapeutics Limited (GDTC) price history — frequently asked questions
How has CytoMed Therapeutics Limited performed over the last year?
CytoMed Therapeutics Limited (GDTC) has fallen 50.0% over the last twelve months, measured on price alone.
What is CytoMed Therapeutics Limited's five-year return?
Over five years the GDTC share price has gained 0.0%, excluding dividends.
What is CytoMed Therapeutics Limited's 52-week range?
Over the last year CytoMed Therapeutics Limited (GDTC) has traded between $0.68 and $3.68.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.